Stabilization of c-KIT G-Quadruplex DNA Structures by the RNA Polymerase I Inhibitors BMH-21 and BA-41.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
04 Oct 2019
Historique:
received: 31 08 2019
revised: 26 09 2019
accepted: 01 10 2019
entrez: 9 10 2019
pubmed: 9 10 2019
medline: 11 2 2020
Statut: epublish

Résumé

The stabilization of G-quadruplex DNA structures by small molecules with affinity to oncogene promoters has emerged as a promising anticancer strategy, due to a potential role in gene expression regulation. We explored the ability of BMH-21 (

Identifiants

pubmed: 31590335
pii: ijms20194927
doi: 10.3390/ijms20194927
pmc: PMC6801708
pii:
doi:

Substances chimiques

BMH-21 0
Heterocyclic Compounds, 4 or More Rings 0
Proto-Oncogene Proteins c-kit EC 2.7.10.1
RNA Polymerase I EC 2.7.7.6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

J Am Chem Soc. 2011 Mar 2;133(8):2658-63
pubmed: 21294544
Eur Biophys J. 2005 Jun;34(4):273-84
pubmed: 15803330
J Mol Graph Model. 1999 Feb;17(1):57-61
pubmed: 10660911
Hum Genet. 1988 Apr;78(4):374-6
pubmed: 3360448
J Med Chem. 2009 Jun 25;52(12):3774-83
pubmed: 19469547
Nat Rev Mol Cell Biol. 2017 May;18(5):279-284
pubmed: 28225080
EMBO J. 1987 Nov;6(11):3341-51
pubmed: 2448137
Oncotarget. 2016 Apr 19;7(16):21658-75
pubmed: 26942875
Structure. 1993 Dec 15;1(4):263-82
pubmed: 8081740
Nucleic Acids Res. 2010 Aug;38(14):4877-88
pubmed: 20348136
J Comput Chem. 2007 Apr 30;28(6):1145-52
pubmed: 17274016
ACS Med Chem Lett. 2013 Aug 13;4(10):909-14
pubmed: 24900584
Exp Cell Res. 2002 Feb 1;273(1):95-106
pubmed: 11795950
Oncotarget. 2014 Jun 30;5(12):4361-9
pubmed: 24952786
Nat Rev Drug Discov. 2011 Apr;10(4):261-75
pubmed: 21455236
Nucleic Acids Res. 2012 Feb;40(4):1499-508
pubmed: 22021377
Biochemistry. 2005 Dec 13;44(49):16341-50
pubmed: 16331995
Nat Rev Genet. 2012 Nov;13(11):770-80
pubmed: 23032257
Nucleic Acids Res. 2007;35(22):7698-713
pubmed: 17984069
Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11593-8
pubmed: 12195017
BMC Cancer. 2010 Oct 15;10:559
pubmed: 20950418
Biochim Biophys Acta Gen Subj. 2017 May;1861(5 Pt B):1399-1413
pubmed: 28025083
Nucleic Acids Res. 2005 Oct 20;33(18):6070-80
pubmed: 16239639
Chem Soc Rev. 2011 Dec;40(12):5867-92
pubmed: 21789296
Nucleic Acids Res. 2014 Oct 29;42(19):e149
pubmed: 25143531
Methods Enzymol. 1995;259:221-42
pubmed: 8538456
Biochim Biophys Acta Gen Subj. 2018 Mar;1862(3):615-629
pubmed: 29229300
J Am Chem Soc. 2005 Aug 3;127(30):10584-9
pubmed: 16045346
ChemMedChem. 2015 Apr;10(4):640-9
pubmed: 25694275
Nucleic Acids Res. 2010 Oct;38(19):6757-73
pubmed: 20566478
Biochemistry. 2008 Jan 15;47(2):689-97
pubmed: 18092816
J Am Chem Soc. 2007 Oct 31;129(43):12926-7
pubmed: 17918848
Phys Chem Chem Phys. 2018 Aug 22;20(33):21772-21782
pubmed: 30106067
Biochemistry. 2006 Jun 27;45(25):7854-60
pubmed: 16784237
ACS Med Chem Lett. 2010 Jul 01;1(7):306-10
pubmed: 24900212
Mutat Res. 2001 Jun 2;477(1-2):165-71
pubmed: 11376697
Biophys Chem. 2007 Mar;126(1-3):140-53
pubmed: 16831507
J Mol Biol. 1993 Dec 20;234(4):1171-83
pubmed: 8263919
Biochim Biophys Acta. 2016 Jun;1860(6):1129-38
pubmed: 26922833
Angew Chem Int Ed Engl. 2004 Jan 30;43(6):668-98
pubmed: 14755695
Spectrochim Acta A Mol Biomol Spectrosc. 2018 May 5;196:185-195
pubmed: 29448171
Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6140-5
pubmed: 15079086
Blood. 2008 Aug 15;112(4):946-56
pubmed: 18684881
Jpn J Cancer Res. 1993 Nov;84(11):1136-44
pubmed: 7506248
Biochim Biophys Acta. 2012 Dec;1820(12):1987-96
pubmed: 23000573
Nucleic Acids Res. 2006;34(18):5133-44
pubmed: 16998187

Auteurs

Stefania Mazzini (S)

Department of Food, Environmental and Nutritional Sciences (DEFENS), Division of Chemistry and Molecular Biology, University of Milan, via Celoria 2, 20133 Milan, Italy. stefania.mazzini@unimi.it.

Raimundo Gargallo (R)

Department of Chemical Engineering and Analytical Chemistry, University of Barcelona, Martí I Franqués 1-11, 08028 Barcelona, Spain. raimon_gargallo@ub.edu.

Loana Musso (L)

Department of Food, Environmental and Nutritional Sciences (DEFENS), Division of Chemistry and Molecular Biology, University of Milan, via Celoria 2, 20133 Milan, Italy. loana.musso@unimi.it.

Francesca De Santis (F)

Unit of Immunotherapy and Anticancer innovative Therapeutics, Department of Medical Oncology Fondazione IRCCS, Istituto Nazionale dei Tumori, via Venezian 1, 20133 Milano, Italy. francesca.desantis@istitutotumori.mi.it.

Anna Aviñó (A)

Institute for Advanced Chemistry of Catalonia (IQAC), CSIC, Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Jordi Girona 18-26, E-08034 Barcelona, Spain. aaagma@cid.csic.es.

Leonardo Scaglioni (L)

Department of Food, Environmental and Nutritional Sciences (DEFENS), Division of Chemistry and Molecular Biology, University of Milan, via Celoria 2, 20133 Milan, Italy. leonardo.scaglioni@unimi.it.

Ramon Eritja (R)

Institute for Advanced Chemistry of Catalonia (IQAC), CSIC, Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Jordi Girona 18-26, E-08034 Barcelona, Spain. recgma@cid.csic.es.

Massimo Di Nicola (M)

Unit of Immunotherapy and Anticancer innovative Therapeutics, Department of Medical Oncology Fondazione IRCCS, Istituto Nazionale dei Tumori, via Venezian 1, 20133 Milano, Italy. massimo.dinicola@istitutotumori.mi.it.

Franco Zunino (F)

Unit of Immunotherapy and Anticancer innovative Therapeutics, Department of Medical Oncology Fondazione IRCCS, Istituto Nazionale dei Tumori, via Venezian 1, 20133 Milano, Italy. francofzunino@gmail.com.

Annabella Amatulli (A)

Department of Food, Environmental and Nutritional Sciences (DEFENS), Division of Chemistry and Molecular Biology, University of Milan, via Celoria 2, 20133 Milan, Italy. Annabella.amatulli@gmail.com.

Sabrina Dallavalle (S)

Department of Food, Environmental and Nutritional Sciences (DEFENS), Division of Chemistry and Molecular Biology, University of Milan, via Celoria 2, 20133 Milan, Italy. sabrina.dallavalle@unimi.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH